A detailed history of Nissay Asset Management Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 11,574 shares of NBIX stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,574
Previous 11,173 3.59%
Holding current value
$1.34 Million
Previous $1.54 Million 3.44%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $52,474 - $57,419
401 Added 3.59%
11,574 $1.59 Million
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $30,383 - $33,491
233 Added 2.13%
11,173 $1.54 Million
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $37,548 - $46,997
354 Added 3.34%
10,940 $1.44 Million
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $33,283 - $41,453
354 Added 3.46%
10,586 $1.19 Million
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $17,100 - $20,030
-191 Reduced 1.83%
10,232 $964,000
Q1 2023

May 15, 2023

SELL
$94.11 - $123.02 $37,832 - $49,454
-402 Reduced 3.71%
10,423 $1.06 Million
Q4 2022

Feb 14, 2023

SELL
$106.72 - $127.06 $25,292 - $30,113
-237 Reduced 2.14%
10,825 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $39,664 - $46,466
431 Added 4.05%
11,062 $1.18 Million
Q2 2022

Aug 15, 2022

SELL
$75.79 - $100.07 $9,852 - $13,009
-130 Reduced 1.21%
10,631 $1.04 Million
Q1 2022

May 16, 2022

BUY
$72.45 - $94.81 $19,199 - $25,124
265 Added 2.52%
10,761 $1.01 Million
Q4 2021

Feb 14, 2022

BUY
$79.65 - $106.22 $33,373 - $44,506
419 Added 4.16%
10,496 $894,000
Q3 2021

Nov 10, 2021

BUY
$86.18 - $99.03 $35,247 - $40,503
409 Added 4.23%
10,077 $966,000
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $39,349 - $44,998
440 Added 4.77%
9,668 $941,000
Q1 2021

May 11, 2021

SELL
$87.57 - $119.4 $19,440 - $26,506
-222 Reduced 2.35%
9,228 $897,000
Q4 2020

Feb 08, 2021

BUY
$86.91 - $108.33 $31,113 - $38,782
358 Added 3.94%
9,450 $906,000
Q3 2020

Oct 20, 2020

BUY
$96.16 - $135.15 $22,789 - $32,030
237 Added 2.68%
9,092 $874,000
Q2 2020

Jul 27, 2020

BUY
$85.09 - $130.36 $98,619 - $151,087
1,159 Added 15.06%
8,855 $1.08 Million
Q1 2020

May 05, 2020

BUY
$75.11 - $113.76 $23,884 - $36,175
318 Added 4.31%
7,696 $666,000
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $640,410 - $874,809
7,378 New
7,378 $793,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.